Met Life Investment Management, LLC Surmodics Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Surmodics Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 8,282 shares of SRDX stock, worth $327,801. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,282
Previous 8,282 -0.0%
Holding current value
$327,801
Previous $348,000 7.76%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$25.39 - $42.1 $19,728 - $32,711
777 Added 10.35%
8,282 $348,000
Q1 2024

May 14, 2024
BUY
$27.44 - $35.56 $205,937 - $266,877
7,505 New
7,505 $220,000
Q2 2023

Apr 29, 2024
BUY
$17.67 - $31.31 $132,613 - $234,981
7,505 New
7,505 $234,000
Q1 2023

May 09, 2024
BUY
$17.13 - $38.52 $128,560 - $289,092
7,505 New
7,505 $171 Million
Q1 2022

May 10, 2024
BUY
$40.68 - $49.72 $305,303 - $373,148
7,505 New
7,505 $340,000
Q1 2022

Mar 22, 2023
BUY
$40.68 - $49.72 $112,195 - $137,127
2,758 Added 58.1%
7,505 $340,000
Q1 2022

May 12, 2022
BUY
$40.68 - $49.72 $112,195 - $137,127
2,758 Added 58.1%
7,505 $340,000
Q4 2021

Jun 21, 2023
SELL
$43.21 - $57.6 $119,173 - $158,860
-2,758 Reduced 36.75%
4,747 $228,000
Q3 2021

May 17, 2024
SELL
$52.8 - $60.32 $74,553 - $85,171
-1,412 Reduced 22.93%
4,747 $263,000
Q3 2021

Jun 21, 2023
SELL
$52.8 - $60.32 $145,622 - $166,362
-2,758 Reduced 36.75%
4,747 $263,000
Q3 2021

Mar 22, 2023
SELL
$52.8 - $60.32 $74,553 - $85,171
-1,412 Reduced 22.93%
4,747 $263,000
Q3 2021

Nov 15, 2021
SELL
$52.8 - $60.32 $74,553 - $85,171
-1,412 Reduced 22.93%
4,747 $264,000
Q2 2021

Jun 21, 2023
SELL
$51.29 - $59.15 $69,036 - $79,615
-1,346 Reduced 17.93%
6,159 $334,000
Q1 2021

May 17, 2024
SELL
$42.18 - $56.07 $56,774 - $75,470
-1,346 Reduced 17.93%
6,159 $345,000
Q1 2021

Jun 26, 2023
SELL
$42.18 - $56.07 $56,774 - $75,470
-1,346 Reduced 17.93%
6,159 $345 Million
Q4 2020

Jun 22, 2023
SELL
$35.18 - $43.52 $47,352 - $58,577
-1,346 Reduced 17.93%
6,159 $268,000
Q3 2020

Jun 26, 2023
SELL
$37.98 - $48.72 $51,121 - $65,577
-1,346 Reduced 17.93%
6,159 $239,000
Q2 2020

May 24, 2024
SELL
$31.07 - $44.74 $41,820 - $60,220
-1,346 Reduced 17.93%
6,159 $266 Million
Q2 2020

Jun 26, 2023
SELL
$31.07 - $44.74 $41,820 - $60,220
-1,346 Reduced 17.93%
6,159 $266,000
Q1 2020

Jul 12, 2023
SELL
$22.46 - $42.24 $30,231 - $56,855
-1,346 Reduced 17.93%
6,159 $205,000
Q4 2019

Jul 12, 2023
SELL
$39.01 - $47.51 $52,507 - $63,948
-1,346 Reduced 17.93%
6,159 $255,000
Q3 2019

Jul 12, 2023
SELL
$38.66 - $47.41 $52,036 - $63,813
-1,346 Reduced 17.93%
6,159 $281,000
Q2 2019

Jul 12, 2023
SELL
$38.23 - $47.43 $51,457 - $63,840
-1,346 Reduced 17.93%
6,159 $265,000
Q1 2019

Jul 13, 2023
SELL
$41.26 - $58.35 $55,535 - $78,539
-1,346 Reduced 17.93%
6,159 $267,000
Q4 2018

Jul 13, 2023
SELL
$44.93 - $73.38 $60,475 - $98,769
-1,346 Reduced 17.93%
6,159 $291,000
Q4 2018

Mar 22, 2023
SELL
$44.93 - $73.38 $160,534 - $262,186
-3,573 Reduced 36.71%
6,159 $291,000
Q4 2018

Feb 14, 2019
SELL
$44.93 - $73.38 $160,534 - $262,186
-3,573 Reduced 36.71%
6,159 $291,000
Q3 2018

Jul 13, 2023
SELL
$56.85 - $80.35 $76,520 - $108,151
-1,346 Reduced 17.93%
6,159 $459,000
Q3 2018

Mar 22, 2023
BUY
$56.85 - $80.35 $126,604 - $178,939
2,227 Added 29.67%
9,732 $726,000
Q3 2018

Nov 14, 2018
BUY
$56.85 - $80.35 $203,125 - $287,090
3,573 Added 58.01%
9,732 $726,000
Q4 2017

Feb 15, 2018
BUY
$28.0 - $33.2 $172,452 - $204,478
6,159
6,159 $172,000

Others Institutions Holding SRDX

# of Institutions
126
Shares Held
11.7M
Call Options Held
1.4K
Put Options Held
8.6K
View Full List

About SURMODICS INC

SRDX Quotes by TradingView
  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $554M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email